Valerio Therapeutics Société anonyme (EPA:ALVIO)

France · Delayed Price · Currency is EUR

0.3945

-0.0065 (-1.62%)

Oct 22, 2026, 5:35 PM CEST

EPA:ALVIO Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5.55	2.57	1.79	1.8	1.44	4.06
Revenue Growth	115.66%	43.50%	-0.39%	24.74%	-64.48%	128.72%
Gross Profit	4.4	1.73	1.28	1.27	0.93	3.69
Operating Income	-2.8	-0.55	-16.49	-19.05	-17.11	-5.58
Net Income	-7.05	-4.9	-23.93	-20.34	-19.56	-5.94
Earnings Per Share	-0.02	-0.02	-0.16	-0.15	-0.18	-0.07
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
France	0.7	-	-	-	-
Rest of The World	1.87	1.79	1.8	1.44	4.06
Total	2.57	1.79	1.8	1.44	4.06

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	0.66	1.05	1.18	6.82	14.59	17.89
Total Debt	13.33	8.31	16.56	11	10.13	9.93
Net Cash (Debt)	-12.67	-7.26	-15.38	-4.18	4.45	7.95
Net Cash Growth	-	-	-	-	-44.02%	-3.79%
Net Cash Per Share	-0.03	-0.03	-0.10	-0.03	0.04	0.09

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	3.58	1.84	-12.46	-17.39	-9.44	-8.57
Capital Expenditures	-1.71	-1.32	-0.32	-0.18	-0.49	-0.14
Free Cash Flow	1.86	0.52	-12.78	-17.57	-9.93	-8.71
Free Cash Flow Growth	257.39%	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	79.31%	67.08%	71.39%	70.39%	64.38%	90.94%
Operating Margin	-50.41%	-21.38%	-919.69%	-1058.50%	-1185.93%	-137.42%
Pretax Margin	-121.12%	-180.22%	-1313.66%	-1129.28%	-1335.90%	-143.70%
Profit Margin	-127.07%	-190.36%	-1334.69%	-1130.22%	-1355.65%	-146.16%
FCF Margin	33.56%	20.25%	-712.72%	-976.33%	-688.22%	-214.45%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	47.52	47.52	47.52	47.52	47.52
P/FCF Ratio	105.82	129.48	-	-	-	-
PS Ratio	35.51	26.22	6.44	14.12	10.84	9.48